secwatch.observer — SEC 8-K summary
======================================

Issuer:     FORUM MARKETS Inc (FRMM)
CIK:        0001690080
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001213900-25-067354
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud

180 Life Sciences Stockholders Approve Increase in Authorized Shares and Equity Plan Amendments
--------------------------------------------------------------------------------

- Stockholders approved increase in authorized common stock from 100M to 1B shares on July 24, 2025.
- Fourth Amendment to 2022 Omnibus Incentive Plan approved, raising initial share limit to 5M with annual increases.
- 2025 Option Incentive Plan approved, granting 1M shares in non-qualified stock options.
- Advisory vote on executive compensation and reverse stock split authorization (1:4 to 1:40) also approved.
- Class I directors Lawrence Steinman and Stephen Shoemaker were elected at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690080/000121390025067354/0001213900-25-067354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690080/000121390025067354/ea0250060-8k_180life.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-067354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer